John R. Ohlfest

COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells

Mitsugu Fujita, Gary Kohanbash, Wendy Fellows-Mayle et al. · Cancer Research · 2011 · 376 citations · Full text

Chemoprevention Strategy, Immunology, Cancer Biology +19

Immunogenicity of Murine Solid Tumor Models as a Defining Feature of In Vivo Behavior and Response to Immunotherapy

Melissa G. Lechner, Saman S. Karimi, Keegan Barry-Holson et al. · Journal of Immunotherapy · 2013 · 360 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +24

Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression

Marianela Candolfi, James F. Curtin, W. Stephen Nichols et al. · Journal of Neuro-Oncology · 2007 · 342 citations · Full text

Intracranial Glioblastoma Models, High-grade Gliomas, Brain Lesion +16

Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux

Sagar Agarwal, Ramola Sane, Jose L. Gallardo et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 249 citations · Full text

CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer

Suresh Kumar Swaminathan, Émilie Roger, Udaya S. Toti et al. · Journal of Controlled Release · 2013 · 192 citations

Breast Oncology, Medicine, Immunology +11